Enanta Pharmaceuticals | ENTA - Текущие активы





Текущие активы Изменить Дата
AbbVie USD 37.48B 3.81B 2026-09
Amgen USD 34.36B 598M 2026-09
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
BioCryst Pharmaceuticals USD 531.15M 46.47M 2026-09
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Heron Therapeutics USD 229.84M 861K 2026-06
Immunic USD 188.76M 165.89M 2026-03
Incyte USD 5.52B 505.2M 2026-09
Insmed USD 1.71B 72.59M 2026-09
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
J&J USD 56.35B 3.42B 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
Merck USD 38.94B 2.26B 2026-09
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Novartis USD 28.75B 1.4B 2026-09
Novavax USD 707.96M 63.14M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09